| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
36,651,000 |
| Market
Cap: |
635.89(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$15.56 - $28.66 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Quanterix is a life sciences company that has developed digital immunoassay platforms. Co.'s platforms are based on its proprietary digital Simoa detection technology. Co. provides the following three Simoa instruments: HD-X, which is based on Co.'s bead-based technology, and assays run on the HD-X are fully automated; SR-X, which utilizes the same Simoa bead-based technology and assay kits as the HD-X in a compact benchtop form with a range of applications; and SP-X, which is based on Co.'s planar array technology, which allows for multiplexing capabilities for oncology and immunology applications.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
20,200 |
639,331 |
| Total Buy Value |
$0 |
$0 |
$501,978 |
$6,053,841 |
| Total People Bought |
0 |
0 |
1 |
7 |
| Total Buy Transactions |
0 |
0 |
1 |
8 |
| Total Shares Sold |
1,000 |
3,500 |
5,000 |
9,187 |
| Total Sell Value |
$23,500 |
$86,935 |
$119,770 |
$189,974 |
| Total People Sold |
1 |
1 |
1 |
5 |
| Total Sell Transactions |
1 |
3 |
4 |
13 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Hrusovsky E Kevin |
Chairman, President & CEO |
• • – |
2020-04-01 |
4 |
S |
$17.44 |
$56,399 |
D/D |
(3,233) |
1,137,367 |
|
-105% |
|
| Roskey Mark T. |
SVP, Commercial & Accelerator |
• – – |
2020-03-31 |
4 |
AS |
$17.44 |
$1,622 |
D/D |
(93) |
21,836 |
|
104% |
|
| Roskey Mark T. |
SVP, Commercial & Accelerator |
• – – |
2020-03-30 |
4 |
AS |
$18.00 |
$90,000 |
D/D |
(5,000) |
21,929 |
|
104% |
|
| Roskey Mark T. |
SVP, Commercial & Accelerator |
• – – |
2020-03-30 |
4 |
OE |
$2.96 |
$14,800 |
D/D |
5,000 |
26,929 |
|
- |
|
| Duffy David C. |
SVP R&D and CTO |
• – – |
2020-03-19 |
4 |
AS |
$11.46 |
$19,104 |
D/D |
(1,667) |
54,526 |
|
102% |
|
| Walt David R |
|
– • – |
2020-03-13 |
4 |
B |
$16.66 |
$900,912 |
D/D |
54,064 |
1,276,374 |
0.01 |
77% |
|
| Roskey Mark T. |
SVP, Commercial & Accelerator |
• – – |
2020-03-13 |
4 |
S |
$16.04 |
$9,081 |
D/D |
(566) |
21,929 |
|
-77% |
|
| Mattoon Dawn |
Sr. VP, Research Products |
• – – |
2020-03-13 |
4 |
S |
$16.04 |
$9,081 |
D/D |
(566) |
32,566 |
|
-77% |
|
| Hrusovsky E Kevin |
Chairman, President & CEO |
• • – |
2020-03-10 |
4 |
AS |
$20.53 |
$112,915 |
D/D |
(5,500) |
1,140,600 |
|
56% |
|
| Madaus Martin D |
|
– • – |
2020-03-05 |
4 |
AS |
$21.79 |
$50,724 |
I/I |
(2,300) |
183,566 |
|
30% |
|
| Madaus Martin D |
|
– • – |
2020-03-05 |
4 |
AS |
$22.99 |
$36,784 |
D/D |
(1,600) |
9,602 |
|
30% |
|
| Madaus Martin D |
|
– • – |
2020-03-05 |
4 |
OE |
$1.93 |
$3,088 |
D/D |
1,600 |
11,202 |
|
- |
|
| Madaus Martin D |
|
– • – |
2020-03-04 |
4 |
AS |
$23.59 |
$54,247 |
I/I |
(2,300) |
185,866 |
|
16% |
|
| Madaus Martin D |
|
– • – |
2020-03-04 |
4 |
AS |
$23.47 |
$37,552 |
D/D |
(1,600) |
9,602 |
|
16% |
|
| Madaus Martin D |
|
– • – |
2020-03-04 |
4 |
OE |
$1.93 |
$3,088 |
D/D |
1,600 |
11,202 |
|
- |
|
| Roskey Mark T. |
SVP, Commercial & Accelerator |
• – – |
2020-03-02 |
4 |
S |
$22.93 |
$1,055 |
D/D |
(46) |
22,495 |
|
-15% |
|
| Mattoon Dawn |
Sr. VP, Research Products |
• – – |
2020-03-02 |
4 |
S |
$22.93 |
$2,636 |
D/D |
(115) |
33,132 |
|
-15% |
|
| Hrusovsky E Kevin |
Chairman, President & CEO |
• • – |
2020-03-02 |
4 |
AS |
$22.40 |
$200,080 |
D/D |
(8,830) |
1,146,100 |
|
15% |
|
| Madaus Martin D |
|
– • – |
2020-02-21 |
4 |
AS |
$27.98 |
$64,359 |
I/I |
(2,300) |
188,166 |
|
-0% |
|
| Madaus Martin D |
|
– • – |
2020-02-21 |
4 |
AS |
$28.26 |
$45,216 |
D/D |
(1,600) |
9,602 |
|
-0% |
|
| Madaus Martin D |
|
– • – |
2020-02-21 |
4 |
OE |
$1.93 |
$3,088 |
D/D |
1,600 |
11,202 |
|
- |
|
| Madaus Martin D |
|
– • – |
2020-02-20 |
4 |
AS |
$28.11 |
$64,705 |
I/I |
(2,300) |
190,466 |
|
-4% |
|
| Madaus Martin D |
|
– • – |
2020-02-20 |
4 |
AS |
$28.29 |
$45,266 |
D/D |
(1,600) |
9,602 |
|
-4% |
|
| Madaus Martin D |
|
– • – |
2020-02-20 |
4 |
OE |
$1.93 |
$3,088 |
D/D |
1,600 |
11,202 |
|
- |
|
| Duffy David C. |
SVP R&D and CTO |
• – – |
2020-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
6,500 |
56,193 |
|
- |
|
686 Records found
|
|
Page 19 of 28 |
|
|
0.53 (2.96%) 
